Nanoencapsulation of Hirudo medicinalis proteins in liposomes as a nanocarrier for inhibiting angiogenesis through targeting VEGFA in the Breast cancer cell line (MCF-7)

[Image: see text] Introduction: Breast cancer is the most serious cause of women’s death throughout the world. Using nanocarrier vehicles to the exact site of cancer upgrades the therapeutic efficiency of the drugs. Capsulation of active proteins in the vesicular liposomes’ hydrophilic core is essen...

Descripción completa

Detalles Bibliográficos
Autores principales: Shakouri, Amir, Kahroba, Houman, Hamishekar, Hamed, Abdolalizadeh, Jalal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences (TUOMS Publishing Group) 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905592/
https://www.ncbi.nlm.nih.gov/pubmed/35411300
http://dx.doi.org/10.34172/bi.2021.39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905592/
https://www.ncbi.nlm.nih.gov/pubmed/35411300
http://dx.doi.org/10.34172/bi.2021.39

Ejemplares similares